Advertisement

Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors

      Abstract

      Background & Aims: Exogenous cholecystokinin (CCK) decreases lower esophageal sphincter (LES) pressure and increases transient LES relaxations (TLESRs) in humans. The aims of this study were to determine whether endogenous CCK increases gastroesophageal reflux in humans and whether this is a direct effect on the LES. Methods: Esophageal pH, LES pressure, and gallbladder volume were measured in 8 healthy volunteers after ingestion of a 181-kcal meal alone or adding 12 g cholestyramine to increase endogenous CCK release. In 7 additional volunteers, the effect of cholestyramine was studied during intravenous perfusion of saline or the CCK-A receptor antagonist loxiglumide. In circular LES strips from 9 transplant donors, we measured the effect of CCK-8 (10−11 to 3 × 10−8 mol/L) on basal tension and on electrical field–induced relaxation. Results: Cholestyramine increased gallbladder emptying, reflux episodes, TLESRs, and time of esophageal pH of <4. Loxiglumide inhibited postprandial gallbladder emptying, reflux episodes, TLESRs, and time of pH of <4 and prevented the decrease in LES pressure induced by cholestyramine. In vitro, CCK-8 contracted LES strips through a tetrodotoxin-insensitive pathway but did not modify electrical field–induced LES relaxations. Conclusions: Endogenous CCK enhances postprandial gastroesophageal reflux in humans by increasing the rate of TLESRs and reduces postprandial LES pressure. These actions seem mediated by extrasphincteric CCK-A receptors that override a direct contractile effect of CCK on the LES muscle.
      GASTROENTEROLOGY 1998;115:597-604

      Abbreviations:

      EC50 (median effective concentration), EFS (electrical field stimulation), L-NNA (Nw-nitro-L-arginine), NANC (nonadrenergic, noncholinergic), TLESR (transient lower esophageal sphincter relaxation)
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dent J
        • Dodds WJ
        • Friedman RH
        • Sekiguchi T
        • Hogan W
        • Arndorfer RC
        • Petrie D.
        Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects.
        J Clin Invest. 1980; 65: 256-267
        • Schoeman MN
        • Tippett MDeM
        • Akkermans LMA
        • Dent J
        • Holloway RH.
        Mechanisms of gastroesophageal reflux in ambulant healthy human subjects.
        Gastroenterology. 1995; 108: 83-91
        • Mittal RK
        • Holloway RH
        • Penagini R
        • Blackshaw LA
        • Dent J.
        Transient lower esophageal sphincter relaxation.
        Gastroenterology. 1995; 109: 601-610
        • Resin H
        • Stern DH
        • Sturdevant RAL
        • Isenberg JI.
        Effect of the C-terminal octapeptide of cholecystokinin on lower esophageal sphincter pressure in man.
        Gastroenterology. 1973; 64: 946-949
        • Fisher RS
        • DiMarino AJ
        • Cohen S.
        Mechanism of cholecystokinin inhibition of esophageal sphincter pressure.
        Am J Physiol. 1975; 228: 1469-1473
        • Dodds WJ
        • Dent J
        • Hogan W
        • Patel GK
        • Toouli J
        • Arndorfer RC.
        Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia.
        Gastroenterology. 1981; 80: 327-333
        • Brazer SR
        • Borislow DS
        • Liddle RA.
        Cholecystokinin is not a major regulator of lower esophageal sphincter pressure.
        Gastroenterology. 1990; 99: 641-645
        • Ledeboer M
        • Masclee AAM
        • Batstra MR
        • Jansen JBMJ
        • Lamers CBHW
        Effect of cholecystokinin on lower esophageal sphincter pressure and transient lower esophageal sphincter relaxations in humans.
        Gut. 1995; 36: 39-44
        • Behar J
        • Biancani P.
        Effect of cholecystokinin-octapeptide on lower esophageal sphincter.
        Gastroenterology. 1977; 73: 57-61
        • Salapatek AM
        • Hynna-Liepert T
        • Diamant NE.
        Mechanisms of action of cholecystokinin octapeptide on cat lower esophageal sphincter.
        Am J Physiol. 1992; 263: G419-G425
        • Boulant J
        • Fioramonti J
        • Dapoigny M
        • Bommelaer G.
        Cholecystokinin and nitric oxide in transient lower esophageal sphincter relaxation to gastric distention in dogs.
        Gastroenterology. 1994; 107: 1059-1066
        • Boulant J
        • Mathieu S
        • D'Amato M
        • Abergel A
        • Dapoigny M
        • Bommelaer G.
        Cholecystokinin in transient lower esophageal sphincter relaxations due to gastric distention in humans.
        Gut. 1997; 40: 575-581
        • Liddle RA
        • Goldfine ID
        • Rosen MS
        • Taplitz RA
        • Williams JA.
        Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding and relationship to gallbladder contraction.
        J Clin Invest. 1985; 75: 1144-1152
        • Gómez G
        • Upp JR
        • Lluís F
        • Alexander RW
        • Poston GJ
        • Greeley GH
        • Thompson JC.
        Regulation of the release of cholecystokinin by bile salts in dogs and humans.
        Gastroenterology. 1988; 94: 1036-1046
        • Lilja P
        • Fagan CJ
        • Wiener I
        • Inoue K
        • Watson LC
        • Rayford PL
        • Thompson JC.
        Infusion of pure cholecystokinin in humans. Correlation between plasma concentrations of cholecystokinin and gallbladder size.
        Gastroenterology. 1982; 83: 256-261
        • Holloway RH
        • Penagini R
        • Ireland AC.
        Criteria for objective definition of transient lower esophageal sphincter relaxation.
        Am J Physiol. 1995; 268: G128-G133
        • Holloway RH
        • Kocyan P
        • Dent J.
        Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux.
        Dig Dis Sci. 1991; 36: 1034-1039
        • Dent J
        • Holloway RH
        • Toouli J
        • Dodds WJ.
        Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic reflux.
        Gut. 1988; 29: 1020-1028
        • Tottrup A
        • Forman A
        • Funch-Jensen P
        • Raundahl U
        • Andersson KE.
        Effects of transmural field stimulation in isolated muscle strips from human esophagus.
        Am J Physiol. 1990; 258: G344-G351
        • Tottrup A
        • Forman A
        • Uldbjerg N
        • Funch-Jensen P
        • Anderson KE.
        Mechanical properties of isolated human esophageal smooth muscle.
        Am J Physiol. 1990; 258: G338-G343
        • Elashoff JD.
        Down with multiple t-tests!.
        Gastroenterology. 1981; 80: 615-620
        • Holloway RH
        • Hongo M
        • Berger K
        • McCallum R.
        Gastric distention: a mechanism for postprandial gastroesophageal reflux.
        Gastroenterology. 1985; 89: 779-784
        • Iwakiri K
        • Kobayashi M
        • Kotoyori M
        • Yamada H
        • Sugiura T
        • Nakagawa Y.
        Relationship between postprandial esophageal acid exposure and meal volume and fat content.
        Dig Dis Sci. 1996; 41: 926-930
        • Grundy SM.
        Treatment of hypercholesterolemia by interference with bile acid metabolism.
        Arch Intern Med. 1972; 130: 638-648
        • Liddle RA.
        Cholecystokinin.
        in: Gut peptides. Raven, New York1994: 175-216
        • Niederau C
        • Heintges T
        • Rovati L
        • Strohmeyer G.
        Effects of loxiglumide on gallbladder emptying in healthy volunteers.
        Gastroenterology. 1989; 97: 1331-1336
        • Smout AJP
        • Bogaard JW
        • van Hattum J
        • Akkermans LMA.
        Effects of cimetidine and ranitidine on interdigestive and postprandial lower esophageal sphincter pressures and plasma gastrin levels in normal subjects.
        Gastroenterology. 1985; 88: 557-563
        • Masclee AAM
        • Jansen JBJM
        • Rovati LC
        • Lamers CBHW
        Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in man.
        Dig Dis Sci. 1993; 38: 1889-1892
        • Malagelada JR
        • Azpiroz F.
        Determinants of gastric emptying and transit in the small intestine.
        in: Handbook of physiology. The gastrointestinal system I. American Physiological Society, Bethesda, MD1989: 909-937
        • Liddle RA
        • Morita ET
        • Conrad CK
        • Williams JA.
        Regulation of gastric emptying by cholecystokinin.
        J Clin Invest. 1986; 77: 992-996
        • Hidalgo L
        • Estorch M
        • Rodríguez-Espinosa J
        • Clavé P
        • Farré A
        • Rovati L
        • Lluís F.
        Endogenous cholecystokinin delays gastric emptying and decreases postprandial release of insulin in man.
        Regul Pept. 1992; 40 (abstr): 168
        • Preiksaitis HG
        • Tremblay L
        • Diamant NE.
        Nitric oxide mediates inhibitory nerve effects in human esophagus and lower esophageal sphincter.
        Dig Dis Sci. 1994; 39: 770-775
        • Tokunaga Y
        • Cox KL
        • Itasaka H
        • Concepcion W
        • Nakazato P
        • Esquivel CO.
        Characterization of cholecystokinin receptors on the human sphincter of Oddi.
        Surgery. 1993; 114: 942-950
        • Rattan S
        • Goyal RK.
        Structure-activity relationship of subtypes of cholecystokinin receptors in the cat lower esophageal sphincter.
        Gastroenterology. 1986; 90: 94-102
        • Davidson JS
        • Clarke GD.
        Mechanical properties and sensitivity to CCK of vagal gastric slowly adapting mechanoreceptors.
        Am J Physiol. 1988; 255: G55-G61
        • Moriarty PA
        • Dimaline R
        • Thompson DG
        • Dockray GJ.
        Molecular characterization of cholecystokinin receptors expressed by human and rat vagal afferent neurones.
        Neuroscience. 1997; 79: 905-913
        • Ewart WR
        • Wingate DL.
        Cholecystokinin octapeptide and gastric mechanoreceptor activity in rat brain.
        Am J Physiol. 1983; 244: G613-G617